Drug details

Optison (perflutren protein-type a microspheres)

type of Diagnostic Imaging Agents

Optison (perflutren protein-type A microspheres) Injectable Suspension consists of microspheres of human serum albumin with perflutren for contrast enhancement used during certain ultrasound imaging procedures.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• skin redness,
• itching,
• lightheadedness,
• confusion,
• chest pain,
• severe headache,
• blurred vision,
• pounding in your neck or ears,
• wheezing,
• fainting,
• slow heart rate,
• anxiety,
• trouble breathing,
• cold sweat,
• fast or slow heartbeats,
• weak pulse,
• severe dizziness,
• tight feeling in your chest or throat,
• warmth, redness, numbness, or tingly feeling in the skin,
• weak, and
• shallow breathing

The following drugs are related to Optison, either as a replacement or used together:

• Betapace AF (sotalol hcl)
• Cozaar (losartan potassium)
• Hyzaar (losartan potassium-hydrochlorothiazide)
• Rythmol (propafenone)
• Rythmol SR (propafenose hydrochloride extended release capsules)